Radiotherapy Market Size & Share 2026 - 2034

Radiotherapy Market Size

The global radiotherapy market was estimated at USD 7.7 billion in 2025. The market is expected to grow from USD 8.12 billion in 2026 to USD 13 billion in 2034, at a CAGR of 6% during the forecast period.

Radiotherapy is one of the most effective and widely used cancer treatment options, helping destroy cancer cells and shrink tumors with precisely targeted high-energy radiation such as X-rays, gamma rays, or charged particles. By damaging the DNA of malignant cells, radiotherapy prevents them from multiplying while minimizing harm to surrounding healthy tissue.

Depending on the type and stage of cancer, treatment is delivered either through external beam radiotherapy (EBRT) using a linear accelerator or brachytherapy, where a radioactive source is placed inside or near the tumor. Continuous advances in image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and precision radiation therapy are improving treatment accuracy, patient outcomes, and overall cancer care.

The radiotherapy market is expanding rapidly, primarily due to the rising global burden of cancer and increasing demand for advanced oncology treatment. According to global cancer estimates, cancer incidence is expected to grow significantly by 2040, driven by population aging, lifestyle changes, and environmental risk factors. This growing patient pool is accelerating investments in radiation oncology infrastructure, AI-enabled treatment planning, and next-generation radiotherapy systems across hospitals and cancer centers. At the same time, increasing awareness of early cancer diagnosis and the availability of effective treatment options are encouraging more patients to seek timely radiation therapy.

Government health initiatives, reimbursement support, and awareness campaigns led by organizations such as the American Cancer Society have further strengthened adoption by educating patients and healthcare providers about the benefits of early intervention and precision cancer treatment. As healthcare systems continue to prioritize personalized oncology care and expand access to advanced radiation technologies, demand for radiotherapy equipment and services is expected to witness sustained long-term growth worldwide.

Market Dynamics

Drivers

Technological advancement in radiotherapy

AI-driven planning, image-guided systems, and precision radiation technologies improve treatment accuracy, reduce side effects, and enhance overall patient outcomes globally.

Increasing number of cancer cases globally

Growing cancer incidence, aging populations, and earlier diagnosis continue driving demand for advanced radiotherapy equipment, treatment planning, and oncology services.

Restraint/Challenge

Lack of skilled and experienced healthcare professionals in developing and underdeveloped regions

Shortages of radiation oncologists, physicists, and therapists restrict technology adoption, limiting access to quality radiotherapy treatment in developing regions.

Radiotherapy Market Trends

The radiotherapy market is expanding steadily as governments, healthcare organizations, and private institutions continue to increase investments in cancer care infrastructure, treatment accessibility, and oncology research. Rising public funding is improving access to advanced radiation therapy, particularly in emerging economies where affordability has traditionally limited treatment adoption.

For example, India's Rashtriya Arogya Nidhi (RAN), through the Health Minister's Cancer Patient Fund (HMCPF), provides financial assistance of up to INR 15 lakh for eligible cancer patients while supporting treatment across 27 Regional Cancer Centres (RCCs). Such initiatives enable more patients to receive timely radiation therapy for cancer, strengthening demand for modern radiotherapy systems and expanding the installation of radiation oncology equipment in hospitals and cancer centers. As healthcare spending on cancer treatment continues to rise worldwide, the adoption of advanced radiotherapy solutions is expected to accelerate.

At the same time, continuous technological innovation is transforming the effectiveness and precision of radiotherapy treatment. Modern techniques such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), and proton therapy allow clinicians to deliver highly targeted radiation doses while minimizing damage to surrounding healthy tissues. These advancements improve treatment accuracy, reduce side effects, shorten recovery times, and support better patient outcomes across multiple cancer types.

The growing integration of AI-enabled treatment planning, real-time imaging, and adaptive radiotherapy further enhances workflow efficiency and personalized cancer care. As hospitals increasingly invest in next-generation radiation therapy equipment to improve clinical outcomes and operational performance, technological innovation remains one of the strongest factors driving the global radiotherapy market, supporting long-term growth and reinforcing radiotherapy as a preferred treatment option alongside surgery and systemic therapies.

Radiotherapy Market Analysis

Based on product type, the market is segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. Furthermore, the external beam radiation therapy segment is further sub-segmented into intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy, and other external beam radiation therapies. The external beam radiation therapy segment held revenues of USD 5 billion in the year 2025 and the segment is poised for significant growth at a CAGR of 6% during the forecast period.
 

• The rising prevalence of cancer, especially localized cancers such as breast, prostate, lung, colon, among other types of cancer, is a key catalyst for the growth of this segment.
   
• For instance, as per the 2022 report of Global Cancer Observatory, lung cancer was the most common type of cancer worldwide with 2.5 million cases, followed by breast cancer with 2.3 million cases, then colorectal cancer with 1.9 million cases, prostate cancer with 1.5 million cases, and stomach cancer with 970,000 cases.
   
• Thus, this rising prevalence of various cancers highlights the need for effective treatment options such as external beam radiation therapy, accelerating segmental growth.
   
• Moreover, the technological advancement in proton therapy, a type of external beam radiation therapy, is further pushing segmental growth in the forward direction.
   
• For instance, Varian’s ProBeam system which utilizes advanced technologies such as Pencil Beam Scanning (PBS) and Intensity Modulated Proton Therapy (IMPT), is designed for advanced photon therapy. This system is well known for its precision and can adapt to complex tumor geometries; such technological advancement is stimulating the market growth of the segment.

Based on application, the radiotherapy market is segmented into lung cancer, prostate cancer, breast cancer, cervical cancer, head and neck cancer, and other applications. The breast cancer segment dominated the market and was valued at USD 2.2 million in 2025 with the revenue share of 28.9%.
 

• The rising prevalence of breast cancer is one of the key catalysts for the growth of the segment.
   
• For instance, as per the data from the World Health Organization (WHO), in 2022, around 2.3 million women were diagnosed with breast cancer and approximately 670,000 died due to breast cancer globally.
   
• Moreover, according to the data from the American Cancer Society, in the U.S. it is projected that in 2025 around 316,950 women will be diagnosed with invasive breast cancer, about 59,080 women will be diagnosed with ductal carcinoma in situ, and approximately 42,170 women will die due to breast cancer across the nation.
   
• Thus, as the diagnosis rate of breast cancer increases, the need for effective treatment such as radiotherapy will increase, thereby propelling the market growth.
   

Based on end use, the radiotherapy market is segmented into hospitals, radiotherapy centers and ambulatory surgery centers, and cancer research institutes. The hospitals segment held the largest revenue of USD 3.2 billion in 2025.
 

• The growth of the segment is highly attributed to the availability of cutting-edge technologies in hospitals pertaining to radiotherapy, such as linear accelerators, proton therapy systems, among others.
   
• Moreover, hospitals are a one-stop destination for various cancer therapies such as chemotherapy, immunotherapy, and surgeries such as tumor resection, making this healthcare setting one of the most preferred options for the treatment of cancer among patients.
   
• Additionally, hospitals collaborate with manufacturers to develop technologically advanced radiotherapy systems, further solidifying their position in the fast-pacing market.
   
• For instance, in 2024, the Mayo Clinic and Varian Medical Systems collaborated to enhance their radiotherapy abilities. This partnership was intended to enhance Varian's radiotherapy technology to improve treatment efficacy, reduce side effects, and propel better patient outcomes. Therefore, collectively all these factors stimulate the growth of the hospital segment in the market.

The North America radiotherapy market is forecasted to reach USD 4.6 billion by 2034. The U.S. dominated the North America market with the largest revenue of USD 2.6 billion in 2025.
 

• The growing prevalence of cancer in the U.S. is the key catalyst for the growth of the market in the U.S.
   
• For instance, as per the data from the American Cancer Society, in 2025, around 2,041,910 new cases of cancer are to be diagnosed, and 618,120 cancer-related deaths are projected to occur in the U.S.
   
• Thus, the rising prevalence of cancer in the country is anticipated to stimulate the adoption of advanced treatment options such as radiotherapy, boosting market growth.
   

Europe: The radiotherapy market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The increasing investments from the UK government for improving cancer infrastructure, training programs pertaining to advanced devices and systems such as radiotherapy systems, and investment in modern equipment integrated with AI and machine learning are propelling the growth of the market in the country.
   
• For instance, in February 2025, the UK government announced an investment of 82.6 million pounds for integrating AI technology into cancer treatment and diagnosis.
   
• Thus, such investment is stimulating the advancement of cancer treatment and diagnosis, fostering the adoption of these innovative technologies among healthcare professionals, propelling the market growth in the country.
   

Asia Pacific: Japan radiotherapy market is anticipated to witness lucrative growth between 2025 – 2034.
 

• The country has one of the speediest aging populations. The individuals of this demographic are highly prone to age-related chronic diseases such as cancer, thereby increasing the need for oncology treatments such as radiotherapy among them.
   
• For example, in 2023, projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above, which is about one-third of the population.
   
• Thus, as the population ages in the country, so do the chances of cancer, thereby fostering market growth in the country.
   

Middle East and Africa: The radiotherapy market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The country's government, through various initiatives such as Vision 2030, is expanding the adoption of various cutting-edge technologies including innovative technologies pertaining to cancer treatment such as radiotherapy.
   
• Additionally, the country is prioritizing the establishment of specialized cancer treatment centers and launching public awareness campaigns to promote cancer prevention and early detection. These efforts are stimulating the demand for radiotherapy services in the country.
   

Radiotherapy Market Share

The top five players of the market account for approximately 80.5% of the market share, which includes companies such as Varian Medical Systems, Elekta, Curium, Accuray, and IBA Radiopharma Solutions. A crucial aspect of market strategy involves the frequent introduction of innovations such as proton therapy, intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), among others. Moreover, key industry players command considerable influence in this dynamic landscape, often propelling forward advancements through substantial investments in research and development. Additionally, strategic agreements, acquisitions, and mergers are involved in strengthening market positions and expanding global footprint along with the evolving regulatory landscapes.

Radiotherapy Market Companies

Some of the eminent market participants operating in the radiotherapy industry include:

• Accuray
• Brainlab
• Curium
• Canon Medical Systems
• Elekta
• Hitachi High-Tech
• IBA Radiopharma Solutions
• Isoray Inc.
• Mevion Medical Systems
• Mitsubishi Electric
• Nordion
• NTP Radioisotopes
• RefleXion
• Toshiba Energy Systems and Solutions
• Varian Medical Systems
   
• Varian Medical Systems has a strong global presence with 70 locations worldwide and a workforce of 11,000 employees, as per the company website.
   
• Elekta has a strong financial position; the company reported a total revenue of USD 1,699.1 million for the financial year 2023-2024.
   

Radiotherapy Industry News

• In May 2026, Elekta reported FY2025/26 net sales of approximately USD 1.75 billion, with an adjusted EBIT of approximately USD 215 million and cash flow of approximately USD 146 million. The company also projected 2–4% net sales growth for FY2026/27. 
• In August 2025, Accuray Incorporated reported FY2025 revenue of USD 458.5 million, representing a 3% year-over-year increase. The company also improved its operating income to USD 7.8 million, driven by strong radiotherapy system installations and service revenue.

The radiotherapy market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• External beam radiation therapy
  • Intensity-modulated radiation therapy (IMRT)
  • Image-guided radiation therapy (IGRT)
  • Proton therapy
  • Other external radiation therapies
• Internal radiation therapy
• Systemic radiation therapy

Market, By Application

• Lung cancer
• Prostate cancer
• Breast cancer
• Cervical cancer
• Head and neck cancer
• Other applications

Market, By End Use

• Hospitals
• Radiotherapy centers and ambulatory surgery centers
• Cancer research institutes

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific 
  • China
  • India
  • Japan
  • Australia
• Latin America 
  • Brazil
  • Mexico
• Middle East and Africa 
  • Saudi Arabia
  • South Africa